Financial Daily from THE HINDU group of publications
Friday, Jul 12, 2002

Port Info

Group Sites

Corporate - Announcements

Ranbaxy files application for IV form of Ranbezolid

Our Bureau

NEW DELHI, July 11

RANBAXY Laboratories Ltd has followed up on its oral form of Ranbezolid, a drug that targets hospital-acquired infections, with an intravenous form.

RLL today filed an application for an investigational new drug (IND) with the Drug Controller General of India (DCGI) for the intravenous use of its molecule, Ranbezolid.

An extended spectrum Oxazolidinone, Ranbezolid or RBx 7644 was seen, in its pre-clinical results, to be suitable for treatment of hospital acquired infections such as pneumonia and post-operative wound infections, among other things, a company statement said.

About two months ago, Ranbaxy had announced the filing of an IND application for this molecule in its oral usage form and is said to be scouting for a co-developer in the global market.

Globally it is touted to be the second anti-bacterial molecule of the oxazolidinone class of compounds, the other existing molecule being Linezolid, from Pharmacia Upjohn, industry representatives said.

The development of oral and IV formulations of Ranbezolid would help clinicians treat patients through IV in the hospital premises and through oral therapy on discharge.

While the global size of the antibiotics market is an estimated $ 22 billion, the hospital/ injectibles market is about $ 7 billion, industry-watchers point out.

Send this article to Friends by E-Mail

Stories in this Section
Ranbaxy files application for IV form of Ranbezolid

Amadeus firms up plan to raise market share
Oriental Hotels to pay 45 pc
Apollo Hospitals launches package for diabetics
Can President Bush afford to talk tough?
Dabur moves a step towards demerger — Separates pharma, FMCG businesses
`Corporate governance ratings can curb frauds'
DCA Secy seeks changes in Companies Act
Raunaq Plastics sets up facility near Kolkata
JB Chemicals to set up unit for `Doktor Mom'
Samir Biswas takes over at DCA
Kores India ties up with Brother Intl
Electrolux rights issue runs into rough weather — Company mulling other plans
Lakshmi Synthetic looking down the barrel
LML hopes Freedom will drive it into the black
West Coast Paper plans growth thru acquisitions
Kinetic Intl to be formed in two months
LG Elec registers 42 pc rise in turnover in H1

The Hindu Group: Home | About Us | Copyright | Archives | Contacts | Subscription
Group Sites: The Hindu | Business Line | The Sportstar | Frontline | Home |

Copyright 2002, The Hindu Business Line. Republication or redissemination of the contents of this screen are expressly prohibited without the written consent of The Hindu Business Line